Third Harmonic Bio pulls in $105m Series B

Third Harmonic Bio, a clinical-stage company, has raised $105 million in Series B funding.

Third Harmonic Bio, a clinical-stage company, has raised $105 million in Series B funding. General Atlantic and BVF Partners led the round.

Source: Press Release